SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-021976
Filing Date
2022-09-07
Accepted
2022-09-07 16:18:16
Documents
22
Period of Report
2022-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20220906_8k.htm   iXBRL 8-K 42433
2 EXHIBIT 4.1 ex_420391.htm EX-4.1 100816
3 EXHIBIT 4.2 ex_420392.htm EX-4.2 103101
4 EXHIBIT 5.1 ex_420409.htm EX-5.1 13573
5 EXHIBIT 10.1 ex_420257.htm EX-10.1 219896
6 EXHIBIT 10.2 ex_420258.htm EX-10.2 212378
7 EXHIBIT 10.3 ex_420259.htm EX-10.3 52569
8 EXHIBIT 99.1 ex_420260.htm EX-99.1 13601
13 lowenlogo.jpg GRAPHIC 11717
14 lowensmlogo.jpg GRAPHIC 10715
  Complete submission text file 0001437749-22-021976.txt   1120515

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA rvph-20220906.xsd EX-101.SCH 4056
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20220906_def.xml EX-101.DEF 13922
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20220906_lab.xml EX-101.LAB 18267
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20220906_pre.xml EX-101.PRE 13944
16 EXTRACTED XBRL INSTANCE DOCUMENT rvph20220906_8k_htm.xml XML 4459
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 221231397
SIC: 2834 Pharmaceutical Preparations